**Specifications Table**TableSubject area*Medicine*More specific subject area*Clinical chemistry, Biomarker development, Sphingosine-1-phosphate*Type of data*Tables*How data was acquired*Blood pressure: HEM-705CP (Omron, Tokyo, Japan)HbA*~*1c*~*: Diamat Analyzer (Bio-Rad, Munich, Germany)Total cholesterol, HDL cholesterol, LDL cholesterol, triglycerides and creatinine: Dimension Vista 500 analytical system (Siemens AG, Erlangen, Germany)Sphingosine-1-phosphate: liquid chromatography-tandem mass spectrometry; Varian L1200 MS/MS (Agilent Technologies, Waldbronn, Germany)*Data format*Analyzed*Experimental factors*Blood samples were drawn from the cubital vein of 4.420 participants of the Study of Health in Pomerania (SHIP)-TREND cohort. Aliquots were analyzed immediately or stored at* −80 °C.Experimental features*After the definition of different subgroups within the SHIP-TREND cohort, the subgroups were characterized by clinical as well as laboratory parameters and sphingosine-1-phosphate concentrations.*Data source location*Greifswald, Germany*Data accessibility*Data is with this article.*

**Value of the data**•The data presented in this DIB article provides further insight into subgroup formation and S1P concentrations depending on BMI limit, altered blood lipid levels and smoking status.•The data will facilitate the determination of S1P reference intervals in future population-based cohorts.•The data can be used for establishing S1P as cardiovascular biomarker.

1. Data {#s0005}
=======

In this Data in Brief article, we provide clinical as well as laboratory baseline characteristics and serum sphingosine-1-phosphate (S1P) concentrations that extend the results reported in [@bib1] for four different subgroups of healthy individuals within the Study of Health in Pomerania (SHIP)-TREND cohort. In any case, subjects with cardiovascular disease, diabetes mellitus, hypertension, metabolic syndrome, elevated liver enzymes and/or chronic kidney disease stadium III or IV were excluded. With respect to body mass index (BMI), the exclusion limit for the first subgroup was 25 kg/m^2^ ('BMI\<=25', *n*=805; [Table 1](#t0005){ref-type="table"}) and 35 kg/m^2^ for the second subgroup ('BMI\<=35', *n*=1474; [Table 2](#t0010){ref-type="table"}), respectively. For the third subgroup altered blood lipid levels were an additional exclusion criterion ('Normolipidemia', *n*=740; [Table 3](#t0015){ref-type="table"}) and smoking for the fourth subgroup ('Non-Smokers', *n*=884; [Table 4](#t0020){ref-type="table"}), respectively. Here, in each case the BMI limit was defined as 30 kg/m^2^. All parameters were stratified by gender, median serum S1P concentrations also by age groups.

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Study population {#s0015}
---------------------

The population-based SHIP-TREND cohort comprises 4420 inhabitants of West Pomerania. A detailed description of the cohort study can be found in Völzke et al. [@bib2], [@bib3]. The study conformed to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the University of Greifswald. All participants provided informed written consent. The exclusion criteria for subgroup formation have been precisely defined in [@bib1].

2.2. Clinical and laboratory parameters {#s0020}
---------------------------------------

Clinical data acquisition and analytical procedures, i.e. for determining laboratory data and S1P concentrations, have been reported previously [@bib1].

2.3. Data analysis {#s0025}
------------------

Continuous data are given as median (25th and 75th percentiles). The non-parametric Mann--Whitney U-test was used for comparison between women and men.

We gratefully thank Anna Steenpaß and Mariola Kastner for their excellent technical assistance. The contributions to data collection made by field workers, study physicians, ultrasound technicians, interviewers, and computer assistants are gratefully acknowledged. This work was funded in part by a grant from the DZHK (Deutsches Zentrum für Herz-Kreislauf-Forschung e.V. Grant 81X2400111). The SHIP-TREND study is part of the Community Medicine Research net of the University of Greifswald, Germany, which is funded by the Federal Ministry of Education and Research (Grants 01ZZ9603, 01ZZ0103, and 01ZZ0403), the Ministry of Cultural Affairs as well as the Social Ministry of the Federal State of Mecklenburg-West Pomerania.

###### 

Baseline characteristics and serum S1P concentrations of the subgroup 'BMI\<=25'.

Table 1

                                   **Women**              **Men**                ***p*-Value**
  -------------------------------- ---------------------- ---------------------- ---------------
  *n*                              579                    226                    
  Age, years                       39 (31, 48)            37 (27, 46)            0.001
  Body mass index, kg/m²           22 (21, 24)            23 (22, 24)            \<0.001
  Systolic blood pressure, mmHg    109 (102, 118)         121 (114, 129)         \<0.001
  Diastolic blood pressure, mmHg   70 (65, 75)            73 (68, 79)            \<0.001
  HbA~1c~, %                       4.9 (4.6, 5.3)         5.1 (4.8, 5.4)         \<0.001
  Total cholesterol, mmol/L        5.10 (4.50, 5.90)      4.75 (4.20, 5.70)      0.001
  HDL cholesterol, mmol/L          1.71 (1.47, 1.92)      1.34 (1.14, 1.56)      \<0.001
  LDL cholesterol, mmol/L          2.94 (2.40, 3.56)      2.92 (2.43, 3.62)      0.512
  Triglycerides, mmol/L            0.93 (0.70, 1.25)      1.05 (0.73, 1.43)      0.007
  Serum creatinine, µmol/L         66 (59, 73)            80 (73, 89)            \<0.001
  eGFR, mL/min/1.73 m²             99 (88, 111)           104 (94, 113)          \<0.001
  Sphingosine-1-phosphate, µM      0.802 (0.687, 0.908)   0.788 (0.688, 0.900)   0.874
  20--29 years                     0.820 (0.689, 0.921)   0.796 (0.704, 0.912)   
  30--39 years                     0.806 (0.696, 0.898)   0.796 (0.687, 0.906)   
  40--49 years                     0.786 (0.679, 0.903)   0.754 (0.669, 0.881)   
  50--59 years                     0.811 (0.712, 0.895)   0.773 (0.675, 0.892)   
  \>=60 years                      0.735 (0.653, 0.973)   0.871 (0.716, 0.997)   

Continuous data are given as median (25th, 75th percentile), Mann-Whitney U-test was used for comparison between women and men. eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

###### 

Baseline characteristics and serum S1P concentrations of the subgroup 'BMI\<=35'.

Table 2

                                   **Women**              **Men**                ***p*-Value**
  -------------------------------- ---------------------- ---------------------- ---------------
  *n*                              969                    505                    
  Age, years                       41 (33, 51)            40 (30, 51)            0.058
  Body mass index, kg/m²           24 (22, 27)            25 (23, 27)            \<0.001
  Systolic blood pressure, mmHg    111 (104, 119)         124 (116, 130)         \<0.001
  Diastolic blood pressure, mmHg   71 (67, 76)            75 (70, 80)            \<0.001
  HbA~1c~, %                       5.0 (4.7, 5.3)         5.1 (4.8, 5.4)         \<0.001
  Total cholesterol, mmol/L        5.20 (4.60, 6.00)      5.10 (4.40, 5.80)      0.003
  HDL cholesterol, mmol/L          1.66 (1.44, 1.89)      1.30 (1.13, 1.52)      \<0.001
  LDL cholesterol, mmol/L          3.09 (2.48, 3.68)      3.22 (2.60, 3.83)      0.010
  Triglycerides, mmol/L            0.98 (0.74, 1.32)      1.16 (0.82, 1.60)      \<0.001
  Serum creatinine, µmol/L         67 (59, 73)            83 (75, 91)            \<0.001
  eGFR, mL/min/1.73 m²             98 (86, 110)           99 (89, 111)           0.014
  Sphingosine-1-phosphate, µM      0.808 (0.694, 0.920)   0.797 (0.701, 0.922)   0.653
  20--29 years                     0.820 (0.690, 0.931)   0.781 (0.703, 0.919)   
  30--39 years                     0.807 (0.689, 0.912)   0.813 (0.697, 0.939)   
  40--49 years                     0.806 (0.694, 0.925)   0.782 (0.703, 0.910)   
  50--59 years                     0.805 (0.705, 0.904)   0.807 (0.702, 0.942)   
  60--69 years                     0.851 (0.694, 0.999)   0.818 (0.718, 0.928)   
  \>=70 years                      0.762 (0.674, 0.913)   0.721 (0.619, 0.872)   

Continuous data are given as median (25^th^, 75th percentile), Mann--Whitney U-test was used for comparison between women and men. eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

###### 

Baseline characteristics and serum S1P concentrations of the subgroup 'Normolipidemia'.

Table 3

                                   **Women**              **Men**                ***p*-Value**
  -------------------------------- ---------------------- ---------------------- ---------------
  *n*                              524                    216                    
  Age, years                       38 (31, 45)            34 (27, 46)            0.033
  Body mass index, kg/m²           23 (21, 26)            25 (22, 26)            \<0.001
  Systolic blood pressure, mmHg    110 (103, 118)         123 (115, 130)         \<0.001
  Diastolic blood pressure, mmHg   70 (66, 75)            73 (68, 79)            \<0.001
  HbA~1c~, %                       4.9 (4.6, 5.2)         5.0 (4.8, 5.3)         \<0.001
  Total cholesterol, mmol/L        4.70 (4.20, 5.20)      4.40 (4.10, 4.90)      \<0.001
  HDL cholesterol, mmol/L          1.67 (1.46, 1.90)      1.39 (1.18, 1.56)      \<0.001
  LDL cholesterol, mmol/L          2.65 (2.23, 2.97)      2.63 (2.26, 3.02)      0.221
  Triglycerides, mmol/L            0.89 (0.66, 1.16)      0.90 (0.64, 1.23)      0.639
  Serum creatinine, µmol/L         67 (59, 73)            83 (75, 91)            \<0.001
  eGFR, mL/min/1.73 m²             99 (88, 112)           102 (92, 113)          0.114
  Sphingosine-1-phosphate, µM      0.805 (0.686, 0.918)   0.788 (0.682, 0.920)   0.531
  20--29 years                     0.812 (0.678, 0.935)   0.785 (0.705, 0.881)   
  30--39 years                     0.801 (0.685, 0.902)   0.838 (0.680, 0.954)   
  40--49 years                     0.807 (0.691, 0.920)   0.754 (0.673, 0.883)   
  50--59 years                     0.814 (0.701, 0.885)   0.827 (0.703, 0.973)   
  60--69 years                     0.870 (0.644, 1.069)   0.797 (0.652, 0.893)   
  \>=70 years                      0.745 (0.692, 0.768)   0.612 (0.503, 0.810)   

Continuous data are given as median (25th, 75th percentile), Mann--Whitney U-test was used for comparison between women and men. eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

###### 

Baseline characteristics and serum S1P concentrations of the subgroup 'Non-Smokers'.

Table 4

                                   **Women**              **Men**                ***p*-Value**
  -------------------------------- ---------------------- ---------------------- ---------------
  *n*                              590                    294                    
  Age, years                       42 (34, 53)            41 (32, 51)            0.064
  Body mass index, kg/m²           24 (22, 26)            25 (23, 27)            \<0.001
  Systolic blood pressure, mmHg    111 (104, 120)         124 (116, 130)         \<0.001
  Diastolic blood pressure, mmHg   71 (66, 76)            74 (70, 79)            \<0.001
  HbA~1c~, %                       5.0 (4.6, 5.3)         5.1 (4.8, 5.4)         \<0.001
  Total cholesterol, mmol/L        5.30 (4.60, 6.10)      5.10 (4.40, 5.80)      0.001
  HDL cholesterol, mmol/L          1.71 (1.48, 1.97)      1.33 (1.17, 1.52)      \<0.001
  LDL cholesterol, mmol/L          3.08 (2.47, 3.70)      3.18 (2.61, 3.82)      0.091
  Triglycerides, mmol/L            0.94 (0.70, 1.29)      1.09 (0.79, 1.52)      \<0.001
  Serum creatinine, µmol/L         67 (59, 74)            84 (76, 91)            \<0.001
  eGFR, mL/min/1.73 m²             97 (85, 108)           98 (88, 109)           0.096
  Sphingosine-1-phosphate, µM      0.802 (0.685, 0.910)   0.782 (0.698, 0.908)   0.934
  20--29 years                     0.828 (0.696, 0.933)   0.771 (0.684, 0.860)   
  30--39 years                     0.801 (0.682, 0.901)   0.854 (0.703, 0.969)   
  40--49 years                     0.783 (0.683, 0.896)   0.776 (0.700, 0.904)   
  50--59 years                     0.808 (0.699, 0.896)   0.795 (0.705, 0.871)   
  60--69 years                     0.813 (0.668, 1.010)   0.806 (0.684, 0.903)   
  \>=70 years                      0.766 (0.673, 0.916)   0.705 (0.583, 0.944)   

Continuous data are given as median (25th, 75th percentile), Mann--Whitney U-test was used for comparison between women and men. eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein.

[^1]: Both authors contributed equally.
